The process is likely similar though it embeds automated quality controls presumptively state of the art. Those quality controls likely have low or insignificant variable cost yet deliver significant value
Being that Lovenox is a parental drug, it wouldn't be unusual that quality portion of the COG reached 75%. That's why you have to be careful when comparing pharma financials because some major companies would incorporate company wide functions into their Admin costs rather than specific product costs.
Market Data 
Markets 
AI
